• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠卵巢肿瘤细胞系对顺铂获得性耐药的进一步特征研究。

Further characterization of acquired-resistance to Cisplatin in a rat ovarian tumor-cell line.

作者信息

Chen G, Hutter K, Zeller W

机构信息

GERMAN CANC RES CTR,INST TOXICOL & CHEMOTHERAPY,W-6900 HEIDELBERG,GERMANY. GERMAN CANC RES CTR,INST RADIOL,W-6900 HEIDELBERG,GERMANY.

出版信息

Int J Oncol. 1992 Jul;1(2):135-40. doi: 10.3892/ijo.1.2.135.

DOI:10.3892/ijo.1.2.135
PMID:21584522
Abstract

The proliferation of a rat ovarian tumor cell line (O-342) was completely inhibited by a 2 h exposure to 20 muM cisplatin (DDP) in vitro up to 120 h after its removal, while in its DDP resistant subline (O-342/DDP), the same treatment only caused a transient growth inhibition within the first 24 h post the exposure, followed by the recovery of proliferation at a similar rate as the control cells. DNA interstrand cross links (ISCL) were maximally formed 12 h post DDP treatment in either O-342 or O-342/DDP cells, with a 2.8-fold increase in the sensitive cells at this time (262 vs. 95 rad eq.). After further 12 h incubation, however, 75% of DNA-ISCL was removed in O-342/DDP cells, while only 22% of them were repaired in O-342 cells. DNA single strand breaks (SSB) were produced to a similar extent in both lines but reached a maximum at 12 and 24 h in the resistant and the sensitive cells, respectively. ADP-ribosyl transferase (ADPRT) activity, a DNA repair-associated enzyme, was 2.6-fold higher in O-342/DDP cells compared to the sensitive subline. Following DDP treatment, the activity was stimulated in the sensitive cells with a maximum of about 1.5-fold at 24 h, whereas the inhibitory effect was observed in the resistant cells, although at 12 h it recovered almost to the control level. Flow cytometric analysis showed that there were at least two sub-populations (2n and 4n) in O-342 cells, while only 2n population was observed in O-342/DDP cells. Following DDP exposure, O-342/DDP cells progressed through the cell cycle with only a small and transient accumulation of cells in S-phase at 12 h and 24 h, while in the sensitive cells, it was impossible to distinguish cell-cycle distribution at 12 h due to severe damage, at 24 h most of the cells became arrested in G2-phases, which persisted until the end of the observation (48 h). Our results suggest that both reduced interaction of cellular DNA with DDP and increased DNA repair are contributing factors for development of DDP resistance, which might be directly or indirectly subsequent to alterations of poly (ADP-ribose) metabolism in the resistant cells.

摘要

大鼠卵巢肿瘤细胞系(O-342)在体外暴露于20μM顺铂(DDP)2小时后,其增殖在去除药物后的120小时内完全受到抑制。而在其顺铂耐药亚系(O-342/DDP)中,相同处理仅在暴露后的前24小时内引起短暂的生长抑制,随后增殖恢复,速率与对照细胞相似。在O-342或O-342/DDP细胞中,DNA链间交联(ISCL)在DDP处理后12小时达到最大值,此时敏感细胞中的ISCL增加了2.8倍(262对95拉德当量)。然而,在进一步孵育12小时后,O-342/DDP细胞中75%的DNA-ISCL被去除,而在O-342细胞中只有22%的DNA-ISCL得到修复。DNA单链断裂(SSB)在两个细胞系中产生的程度相似,但分别在耐药细胞和敏感细胞的12小时和24小时达到最大值。一种与DNA修复相关的酶——ADP-核糖基转移酶(ADPRT)的活性,在O-342/DDP细胞中比敏感亚系高2.6倍。DDP处理后,敏感细胞中的该活性受到刺激,在24小时时最大增加约1.5倍,而在耐药细胞中观察到抑制作用,尽管在12小时时其几乎恢复到对照水平。流式细胞术分析表明,O-342细胞中至少有两个亚群(2n和4n),而在O-342/DDP细胞中仅观察到2n亚群。DDP暴露后,O-342/DDP细胞在细胞周期中进展,仅在12小时和24小时时在S期有少量短暂的细胞积累,而在敏感细胞中,由于严重损伤,在12小时时无法区分细胞周期分布,在24小时时大多数细胞停滞在G2期,并持续到观察结束(48小时)。我们的结果表明,细胞DNA与DDP相互作用的减少和DNA修复的增加都是顺铂耐药发展的促成因素,这可能直接或间接地继发于耐药细胞中多聚(ADP-核糖)代谢的改变。

相似文献

1
Further characterization of acquired-resistance to Cisplatin in a rat ovarian tumor-cell line.大鼠卵巢肿瘤细胞系对顺铂获得性耐药的进一步特征研究。
Int J Oncol. 1992 Jul;1(2):135-40. doi: 10.3892/ijo.1.2.135.
2
Multiple effects of 3-aminobenzamide on DNA damage induced by cisplatin (DDP) in DDP-sensitive and -resistant rat ovarian tumor cell lines.
Cancer Lett. 1992 Oct 30;67(1):27-33. doi: 10.1016/0304-3835(92)90005-g.
3
Increased poly(ADP-ribose) formation in cisplatin-resistant rat ovarian tumor cells.顺铂耐药大鼠卵巢肿瘤细胞中聚(ADP - 核糖)形成增加。
Anticancer Res. 1994 Jul-Aug;14(4A):1461-7.
4
New platinum, titanium, and ruthenium complexes with different patterns of DNA damage in rat ovarian tumor cells.新型铂、钛和钌配合物对大鼠卵巢肿瘤细胞DNA损伤的不同模式
Cancer Res. 1991 Jun 1;51(11):2943-8.
5
In vitro investigations on induction and reversal of cisplatin resistance in a rat ovarian tumor cell line.大鼠卵巢肿瘤细胞系中顺铂耐药性诱导及逆转的体外研究
J Cancer Res Clin Oncol. 1990;116(5):443-7. doi: 10.1007/BF01612991.
6
Reversal of acquired cisplatin resistance by nicotinamide in vitro and in vivo.烟酰胺在体外和体内逆转获得性顺铂耐药性
Cancer Chemother Pharmacol. 1993;33(2):157-62. doi: 10.1007/BF00685335.
7
Synergistic potentiation of Cisplatin cytotoxicity by caffeine in a Cisplatin-resistant rat ovarian tumor-cell line.
Int J Oncol. 1992 Jul;1(2):129-34.
8
Augmentation of cisplatin (DDP) cytotoxicity in vivo by DL-buthionine sulfoximine (BSO) in DDP-sensitive and-resistant rat ovarian tumors and its relation to DNA interstrand cross links.DL-丁硫氨酸亚砜胺(BSO)增强顺铂(DDP)对大鼠顺铂敏感和耐药性卵巢肿瘤的体内细胞毒性及其与DNA链间交联的关系
Anticancer Res. 1991 Nov-Dec;11(6):2231-7.
9
Effects of thaliblastine on cytotoxicity and DNA damage in drug-sensitive and -resistant rat ovarian tumor cells treated with cisplatin.
Anticancer Res. 1993 Jan-Feb;13(1):219-23.
10
Collateral sensitivity to thaliblastine and/or hyperthermia exhibited by a rat ovarian tumor cell line selected for resistance to cisplatin.对顺铂耐药的大鼠卵巢肿瘤细胞系对噻苯达唑和/或热疗表现出的 collateral 敏感性。 注:这里“collateral”可能有误,也许是“collateral sensitivity”应译为“交叉敏感性”等更准确的表述,需结合具体医学背景进一步确认准确含义。
Anticancer Res. 1993 Sep-Oct;13(5A):1269-75.

引用本文的文献

1
Potential role of the HOXD8 transcription factor in cisplatin resistance and tumour metastasis in advanced epithelial ovarian cancer.HOXD8 转录因子在晚期上皮性卵巢癌顺铂耐药和肿瘤转移中的潜在作用。
Sci Rep. 2018 Sep 7;8(1):13483. doi: 10.1038/s41598-018-31030-3.
2
Reversal of acquired cisplatin resistance by nicotinamide in vitro and in vivo.烟酰胺在体外和体内逆转获得性顺铂耐药性
Cancer Chemother Pharmacol. 1993;33(2):157-62. doi: 10.1007/BF00685335.